Genpact LTD (G) stock
GNYSEServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 21/3024% below fair value
$43.61+0.48 (+1.11%)
Close on Nov 13, 2026Market cap $7.33BP/E 12.7Yield 1.56%
Genpact r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Genpact
Genpact has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?